Multilineage DAmFRET to investigate AD/ADRD protein phase behavior in neural tissue models
Multilineage DAmFRET to investigate AD/ADRD protein phase behavior in neural tissue models
批准号:
10583428
负责人:
Randal Arthur Halfmann
金额:
$20.63万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-02-01 至 2025-01-31
关键词:
AffectAgeAlzheimer&aposs DiseaseAlzheimer&aposs disease modelAlzheimer&aposs disease related dementiaAmyloidAstrocytesBacterial Artificial ChromosomesBehaviorBrainCell CommunicationCell NucleusCell VolumesCellsCerebrumChromosomal StabilityClinicalClone CellsCoculture TechniquesComplexCytoplasmDataDementiaDependenceEngineeringEtiologyFlow CytometryFluorescenceFluorescence Resonance Energy TransferFutureGenotypeHomeostasisHumanKineticsMeasurementMicrogliaMicroscopyMolecularNerve DegenerationNeurogliaNeuronsOrganoidsPaintPathogenicityPatientsPhasePhase TransitionPhenotypePhysical condensationPhysiologicalPopulationProteinsRNA-Binding ProteinsReporterSystemThermodynamicsTissue ModelTransfectionTransgenesVariantWorkbiophysical techniquesbrain cellbrain tissuecell typecomorbidityexperimental studyfluorophoreinduced pluripotent stem cellliquid dynamicsmutantneuralpreventpromoterprotein TDP-43protein aggregationprotein expressionproteostasisself assemblytooltranscriptome sequencingtranscriptomics
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract
Alzheimer's Disease and Related Dementias (AD/ADRD) are the most common forms of dementia. No
treatments exist to stop or prevent them. AD/ADRD are caused in part by the aggregation of one, or more often
a combination of, specific proteins. TDP-43 is one of a handful of such proteins. It characteristically transitions
from a dynamic liquid phase of assembly to a rigid and pathogenic phase in a large fraction of dementia cases.
This transition occurs against a backdrop of progressive changes in the interactions between different cell
types in the brain. An interdependence of these molecular and cellular changes likely determines the clinical
courses of AD/ADRD, but to understand that interdependence, we need new tools with which to compare
protein phase transitions and their corresponding phenotype effects in the context of interacting brain cell
types. We propose here to develop such a tool by modifying a cell-based biophysical method, Distributed
Amphifluoric FRET (DAmFRET) for use in human induced pluripotent stem cell (hiPSC)-derived brain tissue
models (Aim 1). We will simultaneously use DAmFRET to develop TDP-43 as a reporter of cell type-specific
differences in the homeostasis of protein phase transitions (Aim 2). By completing these aims, we will have
created and validated a uniquely powerful tool for better understanding the complex molecular and cellular
causes of AD/ADRD.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Elucidating mechanisms of amyloid nucleation in vivo
-
批准号:10320915
-
项目类别:
-
资助金额:$31.76万
-
财政年份:2020
-
负责人:Randal Arthur Halfmann
-
依托单位:
Elucidating mechanisms of amyloid nucleation in vivo
-
批准号:10531912
-
项目类别:
-
资助金额:$31.76万
-
财政年份:2020
-
负责人:Randal Arthur Halfmann
-
依托单位:
Elucidating mechanisms of amyloid nucleation in vivo
-
批准号:9886371
-
项目类别:
-
资助金额:$31.76万
-
财政年份:2020
-
负责人:Randal Arthur Halfmann
-
依托单位:
Contributions of protein aggregation to gene regulation and phenotypic diversity
-
批准号:9104516
-
项目类别:
-
资助金额:$33.0万
-
财政年份:2015
-
负责人:Randal Arthur Halfmann
-
依托单位:
Contributions of protein aggregation to gene regulation and phenotypic diversity
-
批准号:8335441
-
项目类别:
-
资助金额:$31.8万
-
财政年份:2011
-
负责人:Randal Arthur Halfmann
-
依托单位:
Contributions of protein aggregation to gene regulation and phenotypic diversity
-
批准号:8537226
-
项目类别:
-
资助金额:$30.85万
-
财政年份:2011
-
负责人:Randal Arthur Halfmann
-
依托单位:
Contributions of protein aggregation to gene regulation and phenotypic diversity
-
批准号:8213104
-
项目类别:
-
资助金额:$31.7万
-
财政年份:2011
-
负责人:Randal Arthur Halfmann
-
依托单位:
Contributions of protein aggregation to gene regulation and phenotypic diversity
-
批准号:8734278
-
项目类别:
-
资助金额:$31.8万
-
财政年份:2011
-
负责人:Randal Arthur Halfmann
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: